Nephrology
Outcomes Research in Review
Cardioprotective Effect of Metformin in Patients with Decreased Renal Function
FDA/CDC
FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections
The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate...
News
HCV+ kidney transplants: Similar outcomes to HCV- regardless of recipient serostatus
FDA/CDC
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
Conference Coverage
Urine albumin testing is crucial for patients at risk for CKD, but drop the 24-hour urine test
SAN DIEGO – An update on diagnosing, managing, and treating patients with comorbid hypertension and diabetes.
News
NOACs benefit early stage chronic kidney disease patients
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
Latest News
The costs and benefits of SGLT2 inhibitors & GLP-1 RAs
The price tags on these drugs are the biggest barrier to their use.
Conference Coverage
What’s new in pediatric sepsis
LJUBLJANA, SLOVENIA – Don’t obsess about “Golden Hour” for delivering sepsis treatment bundle, expert advises.
Conference Coverage
New diabetes drugs solidify their cardiovascular and renal benefits
CHICAGO –
Conference Coverage
Avoiding in-hospital acute kidney injury is a new imperative
NEW ORLEANS – The myth that acute kidney injury in certain hospitalized patients is inevitable has been destroyed.